Physician profile
John J Lee
NPI 1811973472
$15,254.66
in general payments reported to CMS, 2019-2025
8 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $177 · 2021: $358 · 2022: $5,316 · 2023: $4,881 · 2024: $3,609 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,007 · Food and Beverage: $2,185 · Travel and Lodging: $1,620 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,007.00 |
| Food and Beverage | $2,185.02 |
| Travel and Lodging | $1,619.99 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,333.59 | 2019-2022 | |
| Abbvie INC. | $5,911.94 | 2023-2025 | |
| Merz North America, INC. | $2,749.98 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $126.00 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $46.83 | 2021 | |
| Glaxosmithkline, LLC. | $45.33 | 2019 | |
| Stryker Corporation | $22.83 | 2024 | N/A |
| Galderma Laboratories, L.P. | $18.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.